INTC vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Intel Corp. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intel Corp. · Technology
$127.39
-8.4% upside to fair value
Low Conviction
Grade D
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
JNJ has more upside to fair value
(+5.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
INTC |
JNJ |
| Current Price |
$127.39 |
$270.68 |
| Fair Value Estimate |
$116.75 |
$286.05 |
| Upside to Fair Value |
-8.4%
|
+5.7%
|
| Market Cap |
$642.6B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
185.2x
|
20.2x
|
| Price / Sales |
11.3x
|
6.7x
|
| Price / FCF |
229.7x
|
35.3x
|
| Revenue Growth YoY |
+25.4%
|
+6.6%
|
| Gross Margin |
38.9%
|
67.9%
|
| Operating Margin |
0.1%
|
26.8%
|
| Return on Equity |
-10.8%
|
25.7%
|
| Dividend Yield |
0% |
1.95% |
| FCF Yield |
0.44%
|
2.83%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Intel designs and manufactures CPUs, GPUs, networking silicon, and edge and data-center products across its Client Computing, Data Center and AI, and Intel Foundry segments, employing roughly 85,100 people under CEO Lip-Bu Tan. The business quality is currently low: TTM gross margin is 38.9%, TTM operating margin is 0.1%, TTM net margin is -19.8%, and ROE is -10.8%, so the company is not earning …
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
INTC |
JNJ |
| Zone Low |
$87.56 |
$214.54 |
| Zone High |
$99.24 |
$243.14 |
| In Buy Zone? |
No
|
No
|